Anticoagulants Market 2016 Geographical Segmentation, Size, Trends, Growth and Forecasts
ReportsWeb.com published “Anticoagulants Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 18, 2017 ) Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles.
The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect factor Xa inhibitor, fondaparinux, was released into the market. These drugs were administered by parenteral route.
Publisher's analysts forecast the anti-coagulants market in the US to grow at a CAGR of 6.67% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/anticoagulants-market-in-the-us-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the anti-coagulants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.
Publisher's report, Anti-Coagulants Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-Johnson & Johnson
-Bristol-Myers Squibb
-Boehringer Ingelheim
-Sanofi
-Daiichi Sankyo
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001242763/sample .
Other prominent vendors
-Armatheon Inc.
-Aspen
-AstraZeneca
-Bayer
-Cellceutix
-Cosmo Pharmaceuticals SA
-CSL Behring, Eisai, GSK
-Marathon Pharmaceuticals LLC
-Ockham Biotech
-Perosphere
-Portola Pharmaceuticals
-Sagent Pharmaceuticals Inc.
-The Medicines Company
-Urigen Pharmaceuticals Inc.
-Valeant Pharmaceuticals
Market driver
-Growing prevalence of coagulation disorders
-For a full, detailed list, view our report
Market challenge
-Side-effects associated with drugs
-For a full, detailed list, view our report
Market trend
-Expected exploitation of new therapeutic use
-For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001242763/buying .
The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect factor Xa inhibitor, fondaparinux, was released into the market. These drugs were administered by parenteral route.
Publisher's analysts forecast the anti-coagulants market in the US to grow at a CAGR of 6.67% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/anticoagulants-market-in-the-us-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the anti-coagulants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.
Publisher's report, Anti-Coagulants Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-Johnson & Johnson
-Bristol-Myers Squibb
-Boehringer Ingelheim
-Sanofi
-Daiichi Sankyo
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001242763/sample .
Other prominent vendors
-Armatheon Inc.
-Aspen
-AstraZeneca
-Bayer
-Cellceutix
-Cosmo Pharmaceuticals SA
-CSL Behring, Eisai, GSK
-Marathon Pharmaceuticals LLC
-Ockham Biotech
-Perosphere
-Portola Pharmaceuticals
-Sagent Pharmaceuticals Inc.
-The Medicines Company
-Urigen Pharmaceuticals Inc.
-Valeant Pharmaceuticals
Market driver
-Growing prevalence of coagulation disorders
-For a full, detailed list, view our report
Market challenge
-Side-effects associated with drugs
-For a full, detailed list, view our report
Market trend
-Expected exploitation of new therapeutic use
-For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001242763/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results